Avonex pen 30 MCG/0.5 ML (4PK)s
Ended Awarded
- Contract number
- SPE2DB25FQ3Z8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,390
Award facts
- Contract value 100% obligated
- $12,389.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,389.76 to AmerisourceBergen Drug Corp for the supply of AVONEX Pen 30 mcg/0.5 mL in a four-pack configuration. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was awarded competitively without set-aside designation. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. AVONEX (interferon beta-1a) is a disease-modifying therapy used in the treatment of multiple sclerosis, reflecting the company's role in supplying specialized neurological medications to the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FQ3Z8?
SPE2DB25FQ3Z8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FQ3Z8 worth?
The government has obligated $12,390 on SPE2DB25FQ3Z8.
Is contract SPE2DB25FQ3Z8 an order under another contract?
Yes. SPE2DB25FQ3Z8 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ3Z8 competed?
The extent of competition for SPE2DB25FQ3Z8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award